Ebola Support: Transmission and Prevention Control, Public Health Preparedness, Vaccine Development


Support infection control programs throughout hospitals and other health care facilities to control transmission of Ebola, pathogens similar to Ebola, and those transmitted similarly to Ebola. Identify and implement health care worker requirements, policies and programs for training and competency of infection control practices. Identify and implement prevention activities to reduce transmission of Ebola and other pathogens similar to Ebola.

Support research aimed at development of an Ebola vaccine.

Support efforts to improve public health preparedness for Ebola and other pathogens similar to Ebola. Activities may include enhanced screenings, improvement of rapid notification and response capabilities, training and oversight; development and dissemination of health information, education, and rapid and accurate data exchange.

General information about this opportunity
Last Known Status
Program Number
Federal Agency/Office
Agency: Department of Health and Human Services
Office: Centers for Disease Control and Prevention
Type(s) of Assistance Offered
Cooperative Agreements
Program Accomplishments
Not Applicable.
Public Health Service Act, Sections 301(a)[42U.S.C.241(a)] and 317(k)(2)[42U.S.C.247b(k)(2)].
Who is eligible to apply/benefit from this assistance?
Applicant Eligibility
Eligibility requirements will be delineated in the funding opportunity announcement.
Beneficiary Eligibility
All eligibility requirements will be delineated in the funding opportunity announcement.
No Credentials or documentation are required. This program is excluded from coverage under 2 CFR 200, Subpart E - Cost Principles.
What is the process for applying and being award this assistance?
Pre-Application Procedure
Preapplication coordination is required. Environmental impact information is not required for this program. This program is excluded from coverage under E.O. 12372.
Application Procedure
2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. To apply for research funding opportunities, use application form SF424 (R&R). Submit applications via www.grants.gov
Award Procedure
After review and approval, a notice of award is prepared and processed, along with appropriate notification to the public. Initial awards provides funds for first budget period and Notice of Award indicates support recommended for the remainder of the period of performance.
Contact the headquarters or regional office, as appropriate, for application deadlines.
Approval/Disapproval Decision Time
From 90 to 120 days.
Not Applicable.
If additional support is desired to continue a research project beyond the approved project period, an application for competing continuation must be submitted for review in the same manner as a new application. Projects are renewable for periods of 1 to 3 years.
How are proposals selected?
Applications are reviewed on the basis of scientific/technical merit, with attention given to such matters as: (1) The degree to which the applicant satisfies the essential requirements and possesses other desired characteristics, such as depth, breadth, and scientific merit of the overall application relative to the types of research and demonstration projects proposed; (2) clarity of purpose and overall qualifications, adequacy and appropriateness of personnel to accomplish proposed prevention research projects and demonstration projects, and the nation's health priorities and needs; (3) ability to generalize, translate and disseminate to State or local health departments, boards of education and other appropriate national regional, and local public health agencies and organizations; (4) reasonableness of the proposed budget in relation to the work proposed.
How may assistance be used?
Project funds may be used for costs associated with planning, organizing, conducting, and supporting programs directed towards prevention of disease, disability, and death by control of infectious diseases, and for the implementation of other program elements as described above in Section 50 and through CDC allowable and unallowable expenses. Recipients may only expend funds for reasonable program purposes, including personnel, travel, supplies, and services, such as contractual. Awardees may not generally use HHS/CDC/ATSDR funding for the purchase of furniture or equipment. Any such proposed spending must be identified in the budget. The direct and primary recipient in a cooperative agreement program must perform a substantial role in carrying out project objectives and not merely serve as a conduit for an award to another party or provider who is ineligible. Reimbursement of pre-award costs is not allowed. Recipients may not use funds for construction or building projects. The funding opportunity announcement will describe eligibility and use restrictions. Discretionary funds may be used to fund projects under this CFDA. The funding opportunity announcement will describe funding sources.
What are the requirements after being awarded this opportunity?
Financial status and progress reports are required annually. Upon completion of the project, final financial status and performance reports are required. Interim reporting requirements may be required and will be delineated in the FOA. No cash reports are required. Progress reports are required annually and at the end of the period of performance. Requirements will be delineated in the funding opportunity announcement. Expenditure reports are required and will be described in the funding opportunity announcement. Specific requirements will be laid out in the notice of award.
In accordance with the provisions of 2 CFR 200, Subpart F - Audit Requirements, non-Federal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503. Financial records, supporting documents, statistical records, and all other records pertinent to the project must be kept readily available for review by personnel authorized to examine PHS grant accounts. Records must be maintained for a minimum of 3 years after the period of performance. If questions still remain, such as those raised as a result of an audit, records must be retained until completion or resolution of any audit in process or pending resolution. Property records must be retained in accordance with PHS Grants Policy Statement requirements
No Data Available.
Other Assistance Considerations
Formula and Matching Requirements
This program has no statutory formula.
This program has no matching requirements.
MOE requirements are not applicable to this program.
Length and Time Phasing of Assistance
Normally 1-5 years. All awards are contingent upon availability of funds. See the following for information on how assistance is awarded/released: Specific details will be delineated int he notice of award.
Who do I contact about this opportunity?
Regional or Local Office
See Regional Agency Offices.
Headquarters Office
Gregory J Anderson 1600 Clifton Road NE , Atlanta, Georgia 30052 Email: gca5@cdc.gov Phone: 4047188839
Website Address
No Data Available
Financial Information
Account Identification
75-0943-0-1-550 - Infectious Disease Ebola Related Support.
(Cooperative Agreements) FY 14 $0; FY 15 est $15,000,000; and FY 16 Estimate Not Available
Range and Average of Financial Assistance
No data available.
Regulations, Guidelines and Literature
Not Applicable.
Examples of Funded Projects
Not Applicable.


Federal Grants Resources